Return of research results across the Alzheimer's Disease Research Centers network
Open Access
- 22 June 2025
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (6) , e70418
Abstract
INTRODUCTION: The Consortium for Clarity in Alzheimer's Disease and Related Dementias Through Imaging (CLARiTI) Return of Results Core aims to develop tools and a framework for disclosing individual results at Alzheimer's Disease Research Centers (ADRCs). An understanding of current disclosure practices is necessary to generate this protocol.METHODS: All 37 ADRCs received a survey between January and April 2024; 36 provided valid responses.RESULTS: Most ADRCs disclose diagnosis and cognitive results to participants with impairment, and disclosure of biomarker data (e.g., amyloid and tau positron emission tomography) has accelerated since 2019. Though less common, disclosure to unimpaired participants has increased since 2019. Motivators for disclosure include to thank participants, for recruitment/retention, and to help inform health‐care decisions. Barriers include limited expertise and infrastructure, concerns about clinical actionability, and risks to participants.DISCUSSION: The ADRC network is invested in sharing research results. While some concerns remain, CLARiTI will critically evaluate a standardized approach to sharing these results.Highlights: Individual research results disclosure has increased significantly since 2019. Results are shared more frequently with cognitively unimpaired participants. Disclosure requires interdisciplinary teams including physicians and psychologists. Disclosure motivations include enhancing retention and supporting clinical care. Barriers include limited resources/expertise and potential participant risks.Keywords
This publication has 52 references indexed in Scilit:
- Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapiesMolecular Psychiatry, 2020
- Cognitively unimpaired adults’ reactions to disclosure of amyloid PET scan resultsPLOS ONE, 2020
- Disclosure of amyloid PET scan results: A systematic review2019
- Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data SetAlzheimer Disease & Associated Disorders, 2018
- Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older AdultsJAMA Neurology, 2018
- From information to follow‐up: Ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research settingAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2018
- Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerabilityAlzheimer's & Dementia, 2015
- Confidentiality in preclinical Alzheimer disease studiesNeurology, 2014
- Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer diseaseGenetics in Medicine, 2012
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009